ALNY (Alnylam Corp) Multiplikator Forward P/S

Lambang korporat lan logo Alnylam Pharmaceuticals (ALNY)

Alnylam Pharmaceuticals (ALNY) is driving growth through partnerships with biopharma behemoths in the field of RNA interference, which confirms the forward P/S trend in the GURU.Markets chart data, where 10.00 is the current value of the metric. The company monetizes its ideas through licensing and gene therapy, while its strategy is shifting from rare pathologies toward mass cardiovascular markets, creating new opportunities for investors.

Alnylam - Multiplikator Forward P/S ALNY (periode 04.07.2022 - 16.11.2026)

Ringkesan rincian data analitis Alnylam Pharmaceuticals (ALNY)

- rega pasar lan target rega analis:
Analisis fundamental perusahaan:Alnylam Pharmaceuticals, Inc. ALNY
Produk asli Alnylam Corp

This ratio serves as a stress-testing tool for asset valuation when searching for undervalued securities. It compares current market capitalization with expected sales volume to determine the premium an investor is willing to pay for future revenue growth. The forward P/S indicator for Alnylam Pharmaceuticals (ALNY) reflects market concerns regarding revenue dependence on a narrow portfolio and the risks of late-stage clinical trial failures.

Pesaing Alnylam Pharmaceuticals

Rasio rega marang prakiraan pendapatan Vertex VRTX|INSM (Insmed Inc) - Rega mangsa ngarep marang pendapatan|United Therapeutics - Multiplikator Forward P/S|Rega forward marang dodolan BMRN (BioMarin Pharmaceutical)|BBIO: Multiplikator Forward P/S|BGM Group Corp - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Cogent Bio|XERS: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan kerostx.com (KROS)|Multiplikator forward rega marang pendapatan Arcturus Therapeutics ARCT|Multiplikator Forward P/S ETON (etonpharma.com)|Multiplikator Forward P/S Kamada Ltd KMDA|Fulcrum Therapeutics, Inc. - Multiplikator Forward P/S|ABEO - Multiplikator Forward P/S|MREO: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Protalix BioTherapeutics, Inc. (PLX)|PLRX (Pliant Therapeutics, Inc.) - Multiplikator Forward P/S|Applied Therapeutics Inc. - Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Rein Therapeutics Inc (RNTX)|Rasio rega marang pendapatan sing dikarepake GELS|Aytu BioPharma, Inc. - Multiplikator forward rega marang pendapatan|Chemomab Therapeutics (CMMB) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SRx Health - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Polyrizon Limited PLRZ|AEZS: Multiplikator Forward P/S|CYTH: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan INZY|RPHM: Rega forward marang dodolan|Multiplikator forward rega marang pendapatan CSCI (COSCIENS Biopharma)